Učitavanje...
Progress in Immunotherapy for Non-small Cell Lung Cancer
In recent years, the five-year survival rate of patients with advanced stage non-small cell lung cancer (NSCLC) remains low despite recent advances in surgery, irradiation, chemotherapy, and targeted therapy. Immunotherapy which utilizes the immune system to control and eradicate cancer is a viable...
Spremljeno u:
| Glavni autori: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Chinês |
| Izdano: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2014-01-01
|
| Serija: | Chinese Journal of Lung Cancer |
| Teme: | |
| Online pristup: | http://dx.doi.org/10.3779/j.issn.1009-3419.2014.01.06 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|